Share on StockTwits
 

WellPoint (NYSE:WLP) issued its quarterly earnings data on Wednesday. The company reported $0.87 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.87, AnalystRatings.Net reports. The company had revenue of $17.60 billion for the quarter, compared to the consensus estimate of $17.75 billion.

WLP has been the subject of a number of recent research reports. Analysts at Morgan Stanley reiterated an “equal weight” rating on shares of WellPoint in a research note to investors on Tuesday, January 14th. On a related note, analysts at UBS AG raised their price target on shares of WellPoint from $87.00 to $98.00 in a research note to investors on Monday, November 25th. They now have a “neutral” rating on the stock. Finally, analysts at Zacks downgraded shares of WellPoint from an “outperform” rating to a “neutral” rating in a research note to investors on Friday, November 22nd. They now have a $97.00 price target on the stock. Sixteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $93.53.

Shares of WellPoint (NYSE:WLP) opened at 84.30 on Wednesday. WellPoint has a one year low of $60.41 and a one year high of $94.36. The stock has a 50-day moving average of $89.15 and a 200-day moving average of $87.70. The company has a market cap of $24.904 billion and a P/E ratio of 9.23.

The company also recently announced a quarterly dividend, which is scheduled for Tuesday, March 25th. Stockholders of record on Monday, March 10th will be paid a dividend of 0.4375 per share. This represents a $1.75 annualized dividend and a dividend yield of 2.08%.

WellPoint, Inc (NYSE:WLP) is a health benefit company in terms of medical membership in the United States, serving 34.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.